NCT04668131

Brief Summary

This project is designed as a prospective, randomized, open, controlled clinical trial. For the first time, acupuncture was applied to the treatment of dry ocular neuropathic pain. Its mechanism was discussed by comparing the efficacy between acupuncture and artificial tears.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2020

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 22, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 6, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 16, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2022

Completed
Last Updated

November 23, 2022

Status Verified

September 1, 2020

Enrollment Period

1.5 years

First QC Date

December 6, 2020

Last Update Submit

November 20, 2022

Conditions

Keywords

dry eyepainacupuncture

Outcome Measures

Primary Outcomes (1)

  • Visual Analogue Score

    Ask the patient to mark the corresponding position on the ruler that can represent the pain or discomfort during the onset

    The treatment period for each enrolled subject is one month

Secondary Outcomes (6)

  • OSDI

    The treatment period for each enrolled subject is one month

  • TBUT

    The treatment period for each enrolled subject is one month

  • SIt

    The treatment period for each enrolled subject is one month

  • CFS score

    The treatment period for each enrolled subject is one month

  • Density and curvature of corneal subbasal nerve

    The treatment period for each enrolled subject is one month

  • +1 more secondary outcomes

Study Arms (2)

Artificial tears

EXPERIMENTAL

Artificial tears

Drug: Sodium hyaluronate eye drops

Acupuncture

ACTIVE COMPARATOR

Acupuncture

Other: acupuncture

Interventions

eye drops, three times a day

Also known as: artificial tears
Artificial tears

three times a week

Acupuncture

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • According to the DEWS diagnostic criteria, the OSDI score ≥ 13, with positive signs of dry eye (SIt ≤ 10mm/5min or TBUT ≤ 10s) or CFS positive;
  • VAS\>0;
  • Signed informed consent.

You may not qualify if:

  • Patients with dry eye who have had irritants directly irritating the ocular surface in the past 3 days;
  • Eyeball infections, allergies, deformities, abnormal movements
  • Any history of eye surgery
  • Have had eye trauma or fundus laser treatment within 3 months
  • Used drugs that affect tear production such as antihistamines, antidepressants, etc. within 30 days
  • Suffer from systemic diseases that affect tear production, including Sjogren's syndrome, diabetes, mental illness, malignant tumors, etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Peking University Third Hospital

Beijing, Beijing Municipality, 100191, China

Location

Peking University Third Hospital

Beijing, 100191, China

Location

MeSH Terms

Conditions

Dry Eye SyndromesPain

Interventions

Lubricant Eye DropsAcupuncture Therapy

Condition Hierarchy (Ancestors)

Lacrimal Apparatus DiseasesEye DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Ophthalmic SolutionsPharmaceutical SolutionsSolutionsPharmaceutical PreparationsTherapeutic UsesPharmacologic ActionsChemical Actions and UsesLubricantsSpecialty Uses of ChemicalsComplementary TherapiesTherapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 6, 2020

First Posted

December 16, 2020

Study Start

September 22, 2020

Primary Completion

March 30, 2022

Study Completion

June 30, 2022

Last Updated

November 23, 2022

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share

Locations